Nearly 100 Million Americans Exposed to Unregulated Contaminants in Drinking Water
WEDNESDAY, Jan. 15, 2025 -- More than 97 million U.S. residents are served by U.S. public water systems (PWSs) with detectable levels of contaminants, and disparities related to race, ethnicity, and socioeconomic status are apparent, according to a study published online Jan. 15 in Environmental Health Perspectives.
Aaron J. Maruzzo, M.P.H., from the Silent Spring Institute in Newton, Massachusetts, and colleagues examined determinants of unregulated contaminant detection among U.S. PWSs and assessed disparities related to race, ethnicity, and socioeconomic status. Four target contaminants (or classes) with industrial sources were included: per- and polyfluoroalkyl substances (PFAS); 1,4-dioxane; 1,1-dichloroethane; and chlorodifluoromethane (HCFC-22).
Overall, more than 97 million U.S. residents were served by a PWS with detectable levels of 1,4-dioxane, HCFC-22, 1,1-dichloroethane, and PFAS (22.0, 5.8, 4.7, and 4.0 percent of PWSs, respectively). The researchers found that among large systems, urban systems, and systems using groundwater or a combination of ground water and surface water, unregulated contaminant detection was more frequent. PWSs with detectable levels of these unregulated contaminants served counties with higher proportions of Hispanic residents compared with systems with no detectable levels (17 versus 13 percent); similar results were seen for PWSs that exceeded U.S. Environmental Protection Agency health reference levels compared with systems with no exceedances (18 versus 14 percent). Even after accounting for pollution sources, persistent positive associations were apparent between proportions of Hispanic residents and detection of target contaminants.
"Our findings add to growing evidence of sociodemographic disparities in exposures to drinking water contaminants and indicate that communities of color may have elevated exposures to mixtures of both regulated and unregulated contaminants," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Read this next
Features of Immunesenescence Present in Early Stages of Rheumatoid Arthritis
THURSDAY, Sept. 11, 2025 -- Some features of immunesenescence are present in the very early stages of rheumatoid arthritis (RA), according to a study published online Sept. 3 in...
Urine Biomarker Panel Sensitive, Specific for Prostate Cancer Diagnosis
THURSDAY, Sept. 11, 2025 -- A urine-based biomarker panel has high accuracy for diagnosing prostate cancer (PCa), according to a study published in the September issue of...
Hospitals Vary in Their Definition of Blood Culture Contamination
THURSDAY, Sept. 11, 2025 -- U.S. hospitals vary in how they define blood culture contamination (BCC), according to a study published online July 11 in the Journal of Clinical...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.